000 01740 a2200469 4500
005 20250517232819.0
264 0 _c20200127
008 202001s 0 0 eng d
022 _a2173-5735
024 7 _a10.1016/j.otorri.2018.06.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodríguez-Valiente, Antonio
245 0 0 _al-Thyroxine does not prevent immunemediated sensorineural hearing loss in autoimmune thyroid diseases.
_h[electronic resource]
260 _bActa otorrinolaringologica espanola
_c
300 _a229-234 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibody Specificity
650 0 4 _aAutoantibodies
_ximmunology
650 0 4 _aAutoantigens
_ximmunology
650 0 4 _aCD4-Positive T-Lymphocytes
_ximmunology
650 0 4 _aEar, Inner
_ximmunology
650 0 4 _aFemale
650 0 4 _aHashimoto Disease
_xcomplications
650 0 4 _aHearing Loss, Bilateral
_xetiology
650 0 4 _aHearing Loss, Sensorineural
_xetiology
650 0 4 _aHearing Loss, Unilateral
_xetiology
650 0 4 _aHumans
650 0 4 _aMethylprednisolone
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aSulfate Transporters
_ximmunology
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
650 0 4 _aThyroiditis, Autoimmune
_xcomplications
650 0 4 _aThyroxine
_xtherapeutic use
700 1 _aÁlvarez-Montero, Óscar
700 1 _aGórriz-Gil, Carmen
700 1 _aGarcía-Berrocal, José Ramón
773 0 _tActa otorrinolaringologica espanola
_gvol. 70
_gno. 4
_gp. 229-234
856 4 0 _uhttps://doi.org/10.1016/j.otorri.2018.06.001
_zAvailable from publisher's website
999 _c28730085
_d28730085